The management and outcome of women with post-hydatidiform mole ‘low-risk’ gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l(−1)

por McGrath, S, Short, D, Harvey, R, Schmid, P, Savage, P M, Seckl, M J
Publicado 2010

Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000–2009

por Sita-Lumsden, A, Short, D, Lindsay, I, Sebire, N J, Adjogatse, D, Seckl, M J, Savage, P M
Publicado 2012

A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia

por Powles, T, Savage, P M, Stebbing, J, Short, D, Young, A, Bower, M, Pappin, C, Schmid, P, Seckl, M J
Publicado 2007

The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours

por Powles, T, Young, A, Sammit, A, Stebbing, J, Short, D, Bower, M, Savage, P M, Seckl, M J, Schmid, P
Publicado 2006

The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours

por Powles, T, Young, A, Sanitt, A, Stebbing, J, Short, D, Bower, M, Savage, P M, Seckl, M J, Schmid, P
Publicado 2006

Early prediction of treatment resistance in low-risk gestational trophoblastic neoplasia using population kinetic modelling of hCG measurements

por You, B, Harvey, R, Henin, E, Mitchell, H, Golfier, F, Savage, P M, Tod, M, Wilbaux, M, Freyer, G, Seckl, M J
Publicado 2013

Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia

por Agarwal, R, Harding, V, Short, D, Fisher, R A, Sebire, N J, Harvey, R, Patel, D, Savage, P M, Lim, A K P, Seckl, M J
Publicado 2012